Systematic review and meta-analysis of the risk factors of surgical site infection in patients with colorectal cancer.

Abstract

Background:

Surgical site infection (SSI) influenced the result of surgical treatment, which was known as the second most prevalent hospital-based infection. But, the factors of SSI are not uniform. The purpose of this study was to identify the risk factors of SSI in patients with colorectal cancer. We conducted a meta-analysis of epidemiological research to provide a scientific basis for the prevention of SSI.

Methods:

The PubMed, Medline, Embase, China National Knowledge Infrastructure (CNKI), and Wanfang databases were independently searched by 2 researchers to identify all relevant studies. Studies were selected if they met the selection criteria, which was defined according to the PICOS principles. The quality of the evidence was assessed using Egger's P value, study heterogeneity, and sample size. Studies were categorized into 3 groups as follows: low quality (Class 4), moderate quality (Class 2/3), and high quality (Class 1). The meta-analysis was performed using RevMan 5.3 software.

Results:

A total of 17 studies involving 61,611 patients were included in the meta-analysis. The results identified 7 patient-related risk factors of SSI, including male gender, obesity, diabetes mellitus, American Society of Anesthesiologists (ASA) score, cigarette smoking, tumor location, and serum albumin level, and 5 treatment-related risk factors, including laparoscopic surgery, operation time, blood loss, blood transfusion, and abdominal surgical history. Age was not directly related to SSI in colorectal cancer.

Conclusions:

It is possible that patients can be treated effectively by identifying these factors of SSI.

• Authors: Wenjie Cai, Lina Wang, Weiqiong Wang, Ting Zhou
• Journal: Translational cancer research (Transl Cancer Res) Vol. 11 Issue 4 Pg. 857-871 (Apr 2022) ISSN: 2219-6803 [Electronic] China
• PMID: 35571649 (Publication Type: Journal Article)
• Copyright: 2022 Translational Cancer Research. All rights reserved.